These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2003508)

  • 1. ASHP guidelines for the use of investigational drugs in organized health-care settings.
    Am J Hosp Pharm; 1991 Feb; 48(2):315-9. PubMed ID: 2003508
    [No Abstract]   [Full Text] [Related]  

  • 2. ASHP guidelines for pharmacists on the activities of vendors' representatives in organized health care systems. American Society of Hospital Pharmacists.
    Meyer GE; Keith TD; Gutfeld MB; Johnson D
    Am J Hosp Pharm; 1994 Feb; 51(4):520-1. PubMed ID: 8017422
    [No Abstract]   [Full Text] [Related]  

  • 3. ASHP Guidelines for the Management of Investigational Drug Products.
    Kay SC; Luke DG; Tamer HR
    Am J Health Syst Pharm; 2018 Apr; 75(8):561-573. PubMed ID: 29626006
    [No Abstract]   [Full Text] [Related]  

  • 4. ASHP technical assistance bulletin on use of controlled substances in organized health care settings.
    Am J Hosp Pharm; 1993 Mar; 50(3):489-501. PubMed ID: 8442469
    [No Abstract]   [Full Text] [Related]  

  • 5. ASHP guidelines on pharmacists' relationships with industry.
    Am J Hosp Pharm; 1992 Jan; 49(1):154. PubMed ID: 1510758
    [No Abstract]   [Full Text] [Related]  

  • 6. ASHP statement on the use of medications for unlabeled uses.
    Am J Hosp Pharm; 1992 Aug; 49(8):2006-8. PubMed ID: 1442846
    [No Abstract]   [Full Text] [Related]  

  • 7. Reassessing the membership structure of ASHP.
    Williams RB
    Am J Hosp Pharm; 1992 May; 49(5):1186-90. PubMed ID: 1595751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The exploratory IND.
    Mills G
    J Nucl Med; 2008 Jun; 49(6):45N-47N. PubMed ID: 18511824
    [No Abstract]   [Full Text] [Related]  

  • 9. ASHP and ANA guidelines for collaboration of pharmacists and nurses in institutional care settings.
    Am J Hosp Pharm; 1980 Feb; 37(2):253-4. PubMed ID: 7361801
    [No Abstract]   [Full Text] [Related]  

  • 10. ASHP guidelines for selecting pharmaceutical manufacturers and suppliers.
    Am J Hosp Pharm; 1991 Mar; 48(3):523-4. PubMed ID: 2029002
    [No Abstract]   [Full Text] [Related]  

  • 11. [How and when to create a pediatric file for authorization to market a new drug. A proposal of the SNIP clinical group (National Syndicate of Pharmaceutical Industry)].
    Vasmant D; Abadie E
    Arch Fr Pediatr; 1990 Oct; 47(8):609-13. PubMed ID: 2078114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guidelines for pharmacists and the pharmaceutical industry. The Canadian Society of Hospital Pharmacists.
    Dimens Health Serv; 1990 Nov; 67(8):14-6. PubMed ID: 2276520
    [No Abstract]   [Full Text] [Related]  

  • 13. Opinions of pharmacy, medicine, and pharmaceutical industry leaders about hypothetical therapeutic-interchange legislation.
    Segal R; Grines LL; Pathak DS
    Am J Hosp Pharm; 1988 Mar; 45(3):570-7. PubMed ID: 3369459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ASHP guidelines on pharmaceutical services for ambulatory patients.
    Am J Hosp Pharm; 1991 Feb; 48(2):311-5. PubMed ID: 2003507
    [No Abstract]   [Full Text] [Related]  

  • 15. Enforcement of the current good manufacturing practices for solid oral dosage forms after United States v. Barr Laboratories.
    Jimenez FA
    Food Drug Law J; 1997; 52(1):67-82. PubMed ID: 10346711
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharma's year of trouble and strife.
    Frantz S
    Nat Rev Drug Discov; 2006 Jan; 5(1):7-9. PubMed ID: 16485339
    [No Abstract]   [Full Text] [Related]  

  • 17. ASHP guidelines for the use of investigational drugs in institutions.
    Am J Hosp Pharm; 1979 Feb; 36(2):221-2. PubMed ID: 420212
    [No Abstract]   [Full Text] [Related]  

  • 18. ASHP policy-development process: opportunities for improvement. ASHP Ad Hoc Committee on Policy Development.
    Am J Health Syst Pharm; 1998 May; 55(10):1044-9. PubMed ID: 9606458
    [No Abstract]   [Full Text] [Related]  

  • 19. Health care reform law offers opportunities for pharmacists.
    Batshon L
    Consult Pharm; 2010 Jun; 25(6):388. PubMed ID: 20534410
    [No Abstract]   [Full Text] [Related]  

  • 20. ASCP Reports.
    Jayaprakash A
    Consult Pharm; 2010 Mar; 25(3):186. PubMed ID: 20363713
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.